Search results
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 2 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 2 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 2 days agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 2 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WHTC 1450 Holland· 2 days agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 2 days agoChallenges and Forward Strategy The company is not without its challenges, notably the ongoing need to manage high operational costs and navigate the complex regulatory landscape for
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 2 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 2 days agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WKRN Nashville· 2 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 2 days agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...